LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Freezing Knee Nerves Kills Pain
Large Joints and Extremities

Freezing Knee Nerves Kills Pain

August 4, 2014 1 min read Premium comments

Advertisement

Freezing Knee Nerves Kills Pain
Courtesy: Myoscience, Inc.
Secondary

Vinod Dasa, M.D., an orthopedic surgeon at Louisiana’s State University (LSU) Health Sciences Center, is pioneering the use of iOvera, a nonsurgical pain treatment for patients with arthritis and other knee and joint issues. He sees the use of iOvera as helping close a growing gap between some arthritis patients’ budgets and the treatments available to them to help ease their pain.

With iOvera, Dasa can temporarily freeze the nerves around the knee, alleviating a patient’s pain while avoiding nerve damage or surgery. “Whatever the reason is, this is another tool to try to help them if surgery is not an option or they don’t want surgery right away, ” he said. LSU Health Sciences Center is one of only 20 medical facilities in the U.S. to offer iOvera treatment for orthopedic use.

iOvera uses nitrous oxide canisters to freeze tiny needles to minus 126 degrees. Once they are injected into the skin, the needles freeze the pain nerves and bring instant relief.

“I’ve had some patients that can last for a few weeks. I’ve had other patients gain six to eight months of pain relief, ” Dasa said. “No chemicals, no drug, no nothing—we’re just taking advantage of the natural ability; the body’s natural response to cold, and putting it to our advantage.”

iOvera has been approved by the Food and Drug Administration for pain. It is manufactured by Myoscience, Inc. of Silicon Valley, California. The company was founded in 2005 and is dedicated to focused cold therapy as a treatment for conditions involving nerves.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy